Comprehensive review of fetal adenocarcinoma of the lung
Luisa María Ricaurte,1 Oscar Arrieta,2 Zyanya Lucia Zatarain-Barrón,2 Andrés F Cardona1,3 1Foundation for Clinical and Applied Cancer Research – FICMAC, Bogotá, Colombia; 2Thoracic Oncology Unit, National Cancer Institute (INCan), Méxi...
Saved in:
Main Authors: | Ricaurte LM, Arrieta O, Zatarain-Barrón ZL, Cardona AF |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/b1a5568e4fe842a1a2d5656d0acb2fad |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antiangiogenic therapy in pretreated patients with lung adenocarcinoma without activating mutations: new features
by: Elena V. Reutova, et al.
Published: (2021) -
Trajectory of chemotherapy for patients with EGFR wild-type advanced pulmonary adenocarcinoma: a single-institution retrospective study
by: Minami S, et al.
Published: (2017) -
Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation
by: Qunhao Zheng, et al.
Published: (2021) -
Effect of brain radiotherapy strategies on prognosis of patients with EGFR-mutant lung adenocarcinoma with brain metastasis
by: Guangchuan Deng, et al.
Published: (2021) -
AGTR1 Inhibits the Progression of Lung Adenocarcinoma
by: Xiong L, et al.
Published: (2021)